Clinical Coding for CRS Standards
|
|
- Evelyn McCoy
- 6 years ago
- Views:
Transcription
1 Clinical Coding for CRS Standards The following appendices set out the amended PRIMARY DIAGNOSIS coding structure to be used for the monitoring of cancer waiting times following the implementation of 4th Revision of ICD-10 on 01 April 2012 (see AMD 86/2010). Appendix A: Exclusion of Basal Cell Carcinoma from the Dataset When entering data for patients with a diagnosis coded within ICD-10 C44.0 to C44.9 it is important that patients diagnosed with Basal Cell Carcinoma are excluded from the data-set as they are not covered by the cancer waiting times targets that are to be met by Therefore any definitions of the cancer types that are not to be entered onto the system will have to be defined by the morphology code of the particular neoplasm type as ICD-10 section C44 is classified by affected body area, for example, C44.1 of Eyelid. The table below specifies cancer types/sites to be excluded from the dataset: Specified Neoplasm ICD-10 Classification Morphology Code Basal Cell Carcinoma C44 M8090/3 Multicentric Basal Cell Carcinoma C44 M8091/3 Basal Cell Carcinoma, Morphoea C44 M8092/3 Basal Cell Carcinoma, Fibroepithelial C44 M8093/3 Basosquamos Carcinoma C44 M8094/3 Metatypical Carcinoma C44 M8095/3 Pilomatrix Carcinoma C44 M8110/3 If there is any problem removing a single neoplasm type from your dataset based upon the above information please consult the Basal Cell Neoplasm's section of ICD- O, which can be found under morphology codes M809-M811. No information for any patient diagnosed with a neoplasm that is contained within this section should be entered onto the system. Note: Basal Cell Carcinoma information is required for Cancer Registry purposes. Appendix B: Cancer Report Groupings for Primary Diagnosis (ICD-10) ICD-10 Description 31-Day reporting C00.0 External upper lip C00.1 External lower lip C00.2 External lip, C00.3 lip, inner aspect C00.4 lip, inner aspect C00.5 Lip,, inner aspect C00.6 Commissure of lip
2 C00.8 Overlapping lesion of lip C00.9 Lip, C01 Malignant neoplasm of base of tongue C02.0 Dorsal surface of tongue C02.1 Border of tongue C02.2 Ventral surface of tongue C02.3 Anterior two-thirds of tongue, part C02.4 Lingual tonsil C02.8 Overlapping lesion of tongue C02.9 Tongue, C03.0 gum C03.1 gum C03.9 Gum, C04.0 Anterior floor of mouth C04.1 Lateral floor of mouth C04.8 Overlapping lesion of floor of mouth C04.9 Floor of mouth, C05.0 Hard palate C05.1 Soft palate C05.2 Uvula C05.8 Overlapping lesion of palate C05.9 Palate, C06.0 Cheek mucosa C06.1 Vestibule of mouth C06.2 Retromolar area C06.8 Overlapping lesion of other and parts of mouth C06.9 Mouth, C07 C08 Malignant neoplasm of parotid gland Malignant neoplasm of other and major salivary glands C08.0 Submandibular gland
3 C08.1 Sublingual gland C08.8 Overlapping lesion of major salivary glands C08.9 Major salivary gland, C09 Malignant neoplasm of tonsil C09.0 Tonsillar fossa C09.1 Tonsillar pillar (anterior) (posterior) C09.8 Overlapping lesion of tonsil C09.9 Tonsil, C10.0 Vallecula C10.1 Anterior surface of epiglottis C10.2 Lateral wall of oropharynx C10.3 Posterior wall of oropharynx C10.4 Branchial cleft C10.8 Overlapping lesion of oropharynx C10.9 Oropharynx, C11.0 Superior wall of nasopharynx C11.1 Posterior wall of nasopharynx C11.2 Lateral wall of nasopharynx C11.3 Anterior wall of nasopharynx C11.8 Overlapping lesion of nasopharynx C11.9 Nasopharynx, C12 Malignant neoplasm of pyriform sinus C13.0 Postcricoid region C13.1 Aryepiglottic fold, hypopharyngeal aspect C13.2 Posterior wall of hypopharynx C13.8 Overlapping lesion of hypopharynx C13.9 Hypopharynx, C14.0 Pharynx, C14.2 Waldeyer's ring
4 C14.8 Overlapping lesion of lip, oral cavity and pharynx C15.0 Cervical part of oesophagus C15.1 Thoracic part of oesophagus C15.2 Abdominal part of oesophagus C15.3 third of oesophagus C15.4 Middle third of oesophagus C15.5 third of oesophagus C15.8 Overlapping lesion of oesophagus C15.9 Oesophagus, C16.0 Cardia C16.1 Fundus of stomach C16.2 Body of stomach C16.3 Pyloric antrum C16.4 Pylorus C16.5 Lesser curvature of stomach, C16.6 Greater curvature of stomach, C16.8 Overlapping lesion of stomach C16.9 Stomach, C17.0 Duodenum C17.1 Jejunum
5 C17.2 Ileum C17.3 Meckel's diverticulum C17.8 Overlapping lesion of small intestine C17.9 Small intestine, C18.0 Caecum C18.1 Appendix C18.2 Ascending colon C18.3 Hepatic flexure C18.4 Transverse colon C18.5 Splenic flexure C18.6 Descending colon C18.7 Sigmoid colon C18.8 Overlapping lesion of colon C18.9 Colon, C19 Malignant neoplasm of rectosigmoid junction C20 Malignant neoplasm of rectum C21.0 Anus, C21.1 Anal canal C21.2 Cloacogenic zone C21.8 Overlapping lesion of rectum, anus and anal canal
6 C22.0 Liver cell carcinoma C22.1 Intrahepatic bile duct carcinoma C22.2 Hepatoblastoma C22.3 Angiosarcoma of liver C22.4 sarcomas of liver C22.7 specified carcinomas of liver C22.9 Liver, C23 Malignant neoplasm of gallbladder C24.0 Extrahepatic bile duct C24.1 Ampulla of Vater C24.8 Overlapping lesion of biliary tract C24.9 Biliary tract, C25.0 Head of pancreas C25.1 Body of pancreas C25.2 Tail of pancreas C25.3 Pancreatic duct C25.4 Endocrine pancreas C25.7 parts of pancreas C25.8 Overlapping lesion of pancreas C25.9 Pancreas,
7 C26.0 Intestinal tract, part C26.1 Spleen C26.8 Overlapping lesion of digestive system C26.9 Ill-defined sites within the digestive system C30.0 Nasal cavity C30.1 Middle ear C31.0 Maxillary sinus C31.1 Ethmoidal sinus C31.2 Frontal sinus C31.3 Sphenoidal sinus C31.8 Overlapping lesion of accessory sinuses C31.9 Accessory sinus, C32.0 Glottis C32.1 Supraglottis C32.2 Subglottis C32.3 Laryngeal cartilage C32.8 Overlapping lesion of larynx C32.9 Larynx, C33 Malignant neoplasm of trachea C34.0 Main bronchus C34.1 lobe, bronchus or lung C34.2 Middle lobe, bronchus or lung C34.3 lobe, bronchus or lung C34.8 Overlapping lesion of bronchus and lung C34.9 Bronchus or lung, C37 Malignant neoplasm of thymus C38.0 Heart C38.1 Anterior mediastinum C38.2 Posterior mediastinum C38.3 Mediastinum, part
8 C38.4 Pleura C38.8 Overlapping lesion of heart, mediastinum and pleura C39.0 respiratory tract, part C39.8 Overlapping lesion of respiratory and intrathoracic organs C39.9 Ill-defined sites within the respiratory system C40.0 Scapula and long bones of upper limb C40.1 Short bones of upper limb C40.2 Long bones of lower limb C40.3 Short bones of lower limb C40.8 Overlapping lesion of bone and articular cartilage of limbs C40.9 Bone and articular cartilage of limb, C41.0 Bones of skull and face C41.1 Mandible C41.2 Vertebral column C41.3 Ribs, sternum and clavicle C41.4 Pelvic bones, sacrum and coccyx C41.8 Overlapping lesion of bone and articular cartilage C41.9 Bone and articular cartilage, C43.0 Malignant melanoma of lip C43.1 Malignant melanoma of eyelid, including canthus C43.2 Malignant melanoma of ear and external auricular canal C43.3 Malignant melanoma of other and parts of face C43.4 Malignant melanoma of scalp and neck C43.5 Malignant melanoma of trunk
9 C43.6 Malignant melanoma of upper limb, including shoulder C43.7 Malignant melanoma of lower limb, including hip C43.8 Overlapping malignant melanoma of skin C43.9 Malignant melanoma of skin, C44.0 of lip C44.1 of eyelid, including canthus C44.2 of ear and external auricular canal C44.3 of other and parts of face C44.4 of scalp and neck C44.5 of trunk C44.6 of upper limb, including shoulder C44.7 of lower limb, including hip C44.8 Overlapping lesion of skin C44.9 Malignant neoplasm of skin, C45.0 Mesothelioma of pleura C45.1 Mesothelioma of peritoneum C45.2 Mesothelioma of pericardium C45.7 Mesothelioma of other sites C45.9 Mesothelioma, C46.0 Kaposi's sarcoma of skin C46.1 Kaposi's sarcoma of soft tissue C46.2 Kaposi's sarcoma of palate C46.3 Kaposi's sarcoma of lymph nodes C46.7 Kaposi's sarcoma of other sites C46.8 Kaposi's sarcoma of multiple organs C46.9 Kaposi's sarcoma, C47.0 Peripheral nerves of head, face and neck
10 C47.1 Peripheral nerves of upper limb, including shoulder C47.2 Peripheral nerves of lower limb, including hip C47.3 Peripheral nerves of thorax C47.4 Peripheral nerves of abdomen C47.5 Peripheral nerves of pelvis C47.6 Peripheral nerves of trunk, C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system C47.9 Peripheral nerves and autonomic nervous system, C48.0 Retroperitoneum C48.1 Specified parts of peritoneum C48.2 Peritoneum, C48.8 Overlapping lesion of retroperitoneum and peritoneum C49.0 Connective and soft tissue of head, face and neck C49.1 Connective and soft tissue of upper limb, including shoulder C49.2 Connective and soft tissue of lower limb, including hip C49.3 Connective and soft tissue of thorax C49.4 Connective and soft tissue of abdomen C49.5 Connective and soft tissue of pelvis C49.6 Connective and soft tissue of trunk, C49.8 Overlapping lesion of connective and soft tissue C49.9 Connective and soft tissue,
11 C50.0 Nipple and areola Breast Breast C50.1 Central portion of breast Breast Breast C50.2 -inner quadrant of breast Breast Breast C50.3 -inner quadrant of breast Breast Breast C50.4 -outer quadrant of breast Breast Breast C50.5 -outer quadrant of breast Breast Breast C50.6 Axillary tail of breast Breast Breast C50.8 Overlapping lesion of breast Breast Breast C50.9 Breast, Breast Breast C51.0 Labium majus Gynaecological Gynaecological C51.1 Labium minus Gynaecological Gynaecological C51.2 Clitoris Gynaecological Gynaecological C51.8 Overlapping lesion of vulva Gynaecological Gynaecological C51.9 Vulva, Gynaecological Gynaecological C52 Malignant neoplasm of vagina Gynaecological Gynaecological C53.0 Endocervix Gynaecological Gynaecological C53.1 Exocervix Gynaecological Gynaecological C53.8 Overlapping lesion of cervix uteri Gynaecological Gynaecological C53.9 Cervix uteri, Gynaecological Gynaecological C54.0 Isthmus uteri Gynaecological Gynaecological C54.1 Endometrium Gynaecological Gynaecological C54.2 Myometrium Gynaecological Gynaecological C54.3 Fundus uteri Gynaecological Gynaecological C54.8 Overlapping lesion of corpus uteri Gynaecological Gynaecological C54.9 Corpus uteri, Gynaecological Gynaecological C55 Malignant neoplasm of uterus, part Gynaecological Gynaecological C56 Malignant neoplasm of ovary Gynaecological Gynaecological C57.0 Fallopian tube Gynaecological Gynaecological C57.1 Broad ligament Gynaecological Gynaecological C57.2 Round ligament Gynaecological Gynaecological C57.3 Parametrium Gynaecological Gynaecological C57.4 Uterine adnexa, Gynaecological Gynaecological
12 C57.7 specified female genital organs C57.8 Overlapping lesion of female genital organs Gynaecological Gynaecological Gynaecological Gynaecological C57.9 Female genital organ, Gynaecological Gynaecological C58 Malignant neoplasm of placenta Gynaecological Gynaecological C60.0 Prepuce Urological Urological (Excluding C60.1 Glans penis Urological Urological (Excluding C60.2 Body of penis Urological Urological (Excluding C60.8 Overlapping lesion of penis Urological Urological (Excluding C60.9 Penis, Urological Urological (Excluding C61 Malignant neoplasm of prostate Urological Urological (Excluding C62.0 Undescended testis Urological Testicular C62.1 Descended testis Urological Testicular C62.9 Testis, Urological Testicular C63.0 Epididymis Urological Urological (Excluding C63.1 Spermatic cord Urological Urological (Excluding C63.2 Scrotum Urological Urological (Excluding C63.7 specified male genital organs C63.8 Overlapping lesion of male genital organs Urological Urological Urological (Excluding Urological (Excluding C63.9 Male genital organ, Urological Urological (Excluding C64 C65 Malignant neoplasm of kidney, except renal pelvis Malignant neoplasm of renal pelvis Urological Urological Urological (Excluding Urological (Excluding C66 Malignant neoplasm of ureter Urological Urological (Excluding
13 C67.0 Trigone of bladder Urological Urological (Excluding C67.1 Dome of bladder Urological Urological (Excluding C67.2 Lateral wall of bladder Urological Urological (Excluding C67.3 Anterior wall of bladder Urological Urological (Excluding C67.4 Posterior wall of bladder Urological Urological (Excluding C67.5 Bladder neck Urological Urological (Excluding C67.6 Ureteric orifice Urological Urological (Excluding C67.7 Urachus Urological Urological (Excluding C67.8 Overlapping lesion of bladder Urological Urological (Excluding C67.9 Bladder, Urological Urological (Excluding C68.0 Urethra Urological Urological (Excluding C68.1 Paraurethral glands Urological Urological (Excluding C68.8 Overlapping lesion of urinary organs Urological Urological (Excluding C68.9 Urinary organ, Urological Urological (Excluding C69 Malignant neoplasm of eye and adnexa C69.0 Conjunctiva C69.1 Cornea C69.2 Retina C69.3 Choroid C69.4 Ciliary body
14 C69.5 Lachrymal gland and duct C69.6 Orbit C69.8 Overlapping lesion of eye and adnexa C69.9 Eye, C70.0 Cerebral meninges C70.1 Spinal meninges C70.9 Meninges, C71.0 Cerebrum, except lobes and ventricles C71.1 Frontal lobe C71.2 Temporal lobe C71.3 Parietal lobe C71.4 Occipital lobe C71.5 Cerebral ventricle C71.6 Cerebellum C71.7 Brain stem C71.8 Overlapping lesion of brain C71.9 Brain, C72.0 Spinal cord C72.1 Cauda equina C72.2 Olfactory nerve
15 C72.3 Optic nerve C72.4 Acoustic nerve C72.5 and cranial nerves C72.8 Overlapping lesion of brain and other parts of central nervous system C72.9 Central nervous system, C73 Malignant neoplasm of thyroid gland C74.0 Cortex of adrenal gland C74.1 Medulla of adrenal gland C74.9 Adrenal gland, C75.0 Parathyroid gland C75.1 Pituitary gland C75.2 Craniopharyngeal duct C75.3 Pineal gland C75.4 Carotid body C75.5 Aortic body and other paraganglia C75.8 Pluriglandular involvement, C75.9 Endocrine gland, C76.0 Head, face and neck C76.1 Thorax C76.2 Abdomen C76.3 Pelvis C76.4 limb C76.5 limb C76.7 ill-defined sites C76.8 Overlapping lesion of other and ill-defined sites C77.0 Lymph nodes of head, face and neck C77.1 Intrathoracic lymph nodes
16 C77.2 Intra-abdominal lymph nodes C77.3 Axillary and upper limb lymph nodes C77.4 Inguinal and lower limb lymph nodes C77.5 Intrapelvic lymph nodes C77.8 Lymph nodes of multiple regions C77.9 Lymph node, C78.0 Secondary malignant neoplasm of lung C78.1 Secondary malignant neoplasm of mediastinum C78.2 Secondary malignant neoplasm of pleura C78.3 Secondary malignant neoplasm of other and respiratory organs C78.4 Secondary malignant neoplasm of small intestine C78.5 Secondary malignant neoplasm of large intestine and rectum C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum C78.7 Secondary malignant neoplasm of liver and intrahepetic bile duct C78.8 Secondary malignant neoplasm of other and digestive organs C79.0 Secondary malignant neoplasm of kidney and renal pelvis C79.1 Secondary malignant neoplasm of bladder and other and urinary organs C79.2 Secondary malignant neoplasm of skin C79.3 Secondary malignant neoplasm of brain and cerebral meninges C79.4 Secondary malignant neoplasm of other and parts of nervous system Urological Urological Urological (Excluding Urological (Excluding
17 C79.5 Secondary malignant neoplasm of bone and bone marrow C79.6 Secondary malignant neoplasm of ovary C79.7 Secondary malignant neoplasm of adrenal gland C79.8 Secondary malignant neoplasm of other specified sites C79.9 Secondary malignant neoplasm, site C80.0 Malignant neoplasm,primary site unknown, so stated Gynaecological Gynaecological C80.9 Malignant neoplasm, C81.0 Nodular lymphocyte predominant Hodgkin lymphoma C81.1 Nodular sclerosis classical Hodgkin lymphoma C81.2 Mixed cellularity classical Hodgkin lymphoma C81.3 Lymphocytic depleted classical Hodgkin lymphoma C81.4 Lymphocyte-rich classical Hodgkin lymphoma C81.7 classical Hodgkin disease lymphoma C81.9 Hodgkin's lymphoma, C82.0 Follicular lymphoma grade i C82.1 Follicular lymphoma grade ii
18 C82.2 Follicular lymphoma grade iii, C82.3 Follicular lymphoma grade iiia C82.4 Follicular lymphoma grade iiib C82.5 Diffuse follicle centre lymphoma C82.6 Cutaneous follicle centre lymphoma C82.7 types of follicular lymphoma C82.9 Follicular non-hodgkin's lymphoma, C83.0 B-cell lymphoma C83.1 Mantle cell lymphoma C83.3 Diffuse large B-cell lymphoma C83.5 Lymphoblastic (diffuse) lymphoma C83.7 Burkitt's lymphoma C83.8 types non-follicular lymphoma C83.9 Non-follicular (diffuse) lymphoma,
19 C84.0 Mycosis fungoides C84.1 Sézery's disease C84.4 Peripheral T-cell lymphoma, not elsewhere classified C84.5 mature T/NK-cell lymphomas C84.6 Anaplastic large cell lymphoma, ALK-positive C84.7 Anaplastic large cell lymphoma, ALK-negative C84.8 Cutaneous T-cell lymphoma, C84.9 Mature T/NK-cell lymphoma, C85.2 Mediastinal (thymic)large B-cell lymphoma C85.1 B-cell lymphoma, C85.7 specified types of non- Hodgkin's lymphoma C85.9 Non-Hodgkin's lymphoma, C86.0 Extranodal NK/T-cell lymphoma, nasal type C86.1 Hepatosplenic T-cell lymphoma
20 C86.2 Enteropathy-type (intestinal) T- cell lymphoma C86.3 Subcutaneous panniculitis-like T- cell lymphoma C86.4 Blastic N/K-cell lympthoma C86.5 Angioimmunoblastic T-cell lymphoma C86.6 Primary cutaneous CD30-positive T-cell proliferations C88.0 Waldenström macroglobulinaemia C88.2 heavy chain disease C88.3 Immunoproliferative small intestinal disease C88.4 Extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALTlymphoma) C88.7 malignant immunoproliferative diseases C88.9 Malignant immunoproliferative disease, C90.0 Multiple myeloma C90.1 Plasma cell leukaemia C90.2 Extramedullary plasmacytoma
21 C90.3 Solitary plasmacytoma C91.0 Acute lymphoblastic leukaemia [ALL] C91.1 Chronic lymphocytic leukaemia of B-cell type C91.3 Prolymphocytic leukaemia of B- cell type Acute leukaemia C91.4 Hairy-cell leukaemia C91.5 Adult T-cell lymphoma/leukaemia (HTLV-1-associated) C91.6 Prolymphocytic leukaemia of T- cell type C91.7 lymphoid leukaemia C91.8 Mature B-cell leukaemia Burkitttype Acute Leukaemia C91.9 Lymphoid leukaemia, C92.0 Acute myeloid leukaemia [AML] Acute leukaemia C92.1 Chronic myeloid leukaemia [CML],BCR/ABL-positive C92.2 Atypical chronic myeloid leukaemia, BCR/ABL-negative C92.3 Myeloid sarcoma C92.4 Acute promyelocytic leukaemia [PML] Acute leukaemia C92.5 Acute myelomonocytic leukaemia Acute leukaemia
22 C92.6 Acute myeloid leukaemia with 11q23-abnormality Acute leukaemia C92.7 myeloid leukaemia C92.8 Acute myeloid leukaemia with multilineage dysplasia Acute leukaemia C92.9 Myeloid leukaemia, Acute leukaemia C93.0 Acute monoblastic/monocytic leukaemia C93.1 Chronic myelomonocytic leukaemia C93.3 Juvenile myelomonocytic leukaemia Acute leukaemia C93.7 monocytic leukaemia Acute leukaemia C93.9 Monocytic leukaemia, C94.0 Acute erythroid leukaemia Acute leukaemia C94.2 Acute megakaryoblastic leukaemia Acute leukaemia C94.3 Mast cell leukaemia Acute leukaemia C94.4 Acute panmyelosis with myelofibrosis C94.6 Myelodysplastic and myeloproliferative disease not elsewhere classified C94.7 specified leukaemias Acute leukaemia C95.0 Acute leukaemia of cell type C95.1 Chronic leukaemia of cell type C95.7 leukaemia of cell type Acute leukaemia
23 C95.9 Leukaemia, C96.0 Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis [Letterer-Siwe disease] C96.2 Malignant mast cell tumour C96.4 of dendritic cells (accessory cells) C96.5 Multifocal and unisystemic (disseminated) Langerhans-cell histiocytosis C96.6 Unifocal Langerhans-cell histiocytosis C96.8 Histiocytic sarcoma C96.7 specified malignant neoplasms of lymphoid, haematopoietic and related tissue C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, C97 Malignant neoplasms of independent (primary) multiple sites D05.0 Lobular carcinoma in situ Breast Breast D05.1 Intraductal carcinoma in situ Breast Breast D05.7 carcinoma in situ of breast Breast Breast D05.9 Carcinoma in situ of breast, Breast Breast This coding classification will identify the tumour group of the cancer, the distinction between primary and secondary cancers for reporting purposes is controlled by the CANCER TREATMENT EVENT IDENTIFIER.
82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung
82330 CALCIUM; IONIZED ICD-10 Codes that Support Medical Necessity ICD-10 Code Description A15.0 Tuberculosis of lung A15.4 Tuberculosis of intrathoracic lymph nodes A15.5 Tuberculosis of larynx, trachea
More informationCancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
More informationWLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded
More informationWLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416)
Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor
More informationSerum Iron Studies
190.18 - Serum Iron Studies Serum iron studies are useful in the evaluation of disorders of iron metabolism, particularly iron deficiency and iron excess. Iron studies are best performed when the patient
More informationIntensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr go to Comunicados a Proveedores, and click Cartas Circulares.]
More informationSCCA REFERENCE MANUAL ICD-10
SCCA REFERENCE MANUAL ICD-10 NORTHWEST HOSPITAL 1 BREAST CANCER BREAST (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer
More information155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
More informationCLINICAL MEDICATION POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICATION POLICY Granulocyte Colony Stimulating Factors (G-CSFs) MP-016-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date:
More informationCLINICAL MEDICATION POLICY
Policy Name: Policy Number: Approved By: CLINICAL MEDICATION POLICY Keytruda (pembrolizumab) MP-014-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date: 01/15/2018; 08/01/2017; 06/01/2016
More informationModel Policy. Coverage of Proton Therapy
Model Policy Coverage of Proton Therapy Last Revised - February 2019 INTRODUCTION Proton therapy is a technologically advanced method to deliver curative radiation doses to cancerous tumors. The unique
More informationICD-10 and Radiation Oncology
ICD-10 and Radiation Oncology Steven M. Verno, CEMCS ICD-10 and Radiation Oncology Steven M. Verno, CEMCS September 23, 2008 Note: ICD-9-CM and ICD-10 are owned and copyrighted by the World Health Organization.
More informationCLINICAL MEDICATION POLICY
CLINICAL MEDICATION POLICY Policy Name: Opdivo (nivolumab) injection Policy Number: Approved By: Medical Management, Clinical Pharmacy Products: Highmark Health Options Application: All participating hospitals
More informationCancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
More informationPeripheral Nerve Blocks
Last Review Date: April 21, 2017 Number: MG.MM.ME.64v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationGenetic Testing for Cancer Susceptibility
Last Review Date: March 10, 2017 Number: MG.MM.AD.17v3 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationMALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
MALIGNANT NEOPLASMS OF THE (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer quadrant 5 - Lower-outer quadrant 6 - Axillary
More informationPembrolizumab (Keytruda )
Last Review Date: March 14, 2017 Number: MG.MM.PH.10f Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationCEA (CARCINOEMBRYONIC ANTIGEN)
(CARCINOEMBRYONIC ANTIGEN) 428 C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant
More informationSITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR
SITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR Anus: Anal Canal; Anus, NOS; Other Parts of Rectum C21.0-C21.2, C21.8 C21.0 Anus, NOS (excludes skin of anus and perianal skin C44.5) C21.1 Anal canal C21.2
More informationincidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Document Information
Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information
More informationDATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY
Date: 10 th April 2018 DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Request: 1. Utilization Data of Overseas Beam Therapy and Brachytherapy 2. Diagnoses Data of Overseas Claims for Beam Therapy and Brachytherapy
More informationAnatomical Considerations for Lab Practical II
Anatomical Considerations for Lab Practical II For each of the following please be prepared to provide: Identification System Organ(s) or ducts to Function(s) location which it is attached Use your lecture
More informationGamma Glutamyl Transferase
Other Names/Abbreviations GGT 190.32 - Gamma Glutamyl Transferase Gamma glutamyl transferase (GGT) is an intracellular enzyme that appears in blood following leakage from cells. Renal tubules, liver, and
More informationColony Stimulating Factors: Neupogen (filgrastim), Neulasta (pegfilgrastim), Leukine (sargramostim), Granix (tbo-filgrastim)
Neupogen (filgrastim), Neulasta (sargramostim), Granix (tbo-filgrastim) Date of Origin: 10/17/2008 Dates Reviewed: 6/17/2009, 12/22/2009, 06/15/2010/ 7/20/2010, 09/2010, 12/2010, 03/2011, 06/2011, 09/2011,
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information
Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor
More informationCLINICAL MEDICAL POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Opdivo (nivolumab) MP-004-MC-PA Medical Management; Clinical Pharmacy Provider Notice Date: 09/01/2018; 06/15/2018; 04/01/2017
More information2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information
Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor
More informationAnnual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.
Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and
More informationGroup B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green
Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Digestive system 1. Teeth Main points: external and internal structure of a tooth, fixation of a tooth
More informationSEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl
SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and
More informationANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
More informationNeoplasms/Lymphoma/Leukemia
Neoplasms/Lymphoma/Leukemia Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
More informationTable of Contents. Last updated by CLO: 5/8/2013 1
Table of Contents Drug-induced liver injury algorithm - Cases... 2 Drug-induced liver injury algorithm - Controls... 3 1. Summary of drug-induced liver injury algorithm... 4 2. Terminology... 4 3. Threshold
More informationEND-SEMESTER EXAM 2018 ANATOMY, HISTOLOGY AND EMBRYOLOGY FACULTY OF MEDICINE, 2 ND SEMESTER
University of Szeged, Faculty of Medicine Department of Anatomy, Histology and Embryology Chairman: Prof. Antal Nógrádi MD, PhD, DSc Kossuth L. sgt. 40., H-6724 Szeged, Hungary Tel.: +36-62-545-665 P.
More informationS2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
More informationAPPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
More information2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes
Acute basophilic leukemia 9870/3 Acute biphenotypic leukemia [OBS] 9805/3 Acute erythroid leukemia 9840/3 Acute megakaryoblastic leukemia 9910/3 Acute monoblastic and monocytic leukemia 9891/3 Acute myeloid
More information2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes
Malignant lymphoma, NOS 9590/3 Non-Hodgkin lymphoma, NOS 9591/3 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma 9596/3 Primary
More informationTruman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
More informationIntroduction to ICD-O-3 coding rules
Introduction to ICD-O-3 coding rules Weena Laddachayaporn, MD National Cancer Institute, Bangkok, Thailand ICD-O-3 The International Classification of Diseases for Oncology Is a coding system for primary
More informationAnatomy. Contents Brain (Questions)
Anatomy 12 Contents 12.1 Brain (Questions).................................................... 683 12.2 Head and Neck (Questions)............................................. 685 12.3 Thorax (Questions)...................................................
More informationFlorida Cancer Data System STAT File Documentation Version 2019
Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status
More informationFentora (Fentanyl Buccal)
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Fentora (Fentanyl Buccal) Clinical Edit Information Included in this Document Fentora 100mcg Drugs requiring prior authorization:
More informationCombinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation
Major subgroups according to the World Health Organisation (WHO) Classification Myeloproliferative neoplasms (MPN) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or
More informationMorphine Equivalent Dosing
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class This criteria was recommended for review by the Texas Medicaid Vendor Drug Program to ensure appropriate and safe utilization. Clinical
More informationKhapzory (levoleucovorin) (Intravenous)
Khapzory (levoleucovorin) (Intravenous) Last Review Date: 12/04/2018 Date of Origin: 12/04/2018 Dates Reviewed: 12/2018 Document Number: IC-0408 I. Length of Authorization Coverage will be provided for
More informationMEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site
POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization
More informationFusilev (levoleucovorin) Document Number: IC-0183
Fusilev (levoleucovorin) Document Number: IC-0183 Last Review Date: 2/1/2018 Date of Origin: 01/02/2014 Dates Reviewed: 08/2014, 03/2015, 05/2015, 08/2015, 11/2015, 02/2016, 05/2016, 08/2016, 11/2016,
More informationInterventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies
Web appendix 2: SEARCH STRATEGIES Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies MEDLINE 1. exp epidemiologic studies/
More informationThe original MED criteria can be referenced at the Texas Vendor Drug Program website located at
Morphine Equivalent Dosing (MED) Clinical Edit Criteria Drug/Drug Class Morphine Equivalent Dosing (MED) Superior HealthPlan follows the guidance of the Texas Vendor Drug Program (VDP) for all clinical
More informationNEW/REVISED MATERIAL: Presented in italicized text EFFECTIVE DATE: January 1, 2008 GUIDELINES FOR REPORTING ADMINISTRATION OF EPOGEN MEDICARE
DISCLAIMER: Please be advised that while every effort has been made to ensure the accuracy of the information provided according to the most current LCD pertaining to the subject, periodic change to rules
More informationBRAF Mutation Analysis
Last Review Date: October 13, 2017 Number: MG.MM.LA.38aC Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationCarcinoembryonic Antigen
Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring
More informationKeytruda (pembrolizumab) (Intravenous)
Keytruda (pembrolizumab) (Intravenous) Last Review Date: 02/06/2018 Date of Origin: 09/30/2014 Document Number: IC-0209 Dates Reviewed: 9/2014, 3/2015, 5/2015, 8/2015, 10/2015, 11/2015, 2/2016, 5/2016,
More informationACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS RESPIRATORY SYSTEM
ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS OBJECTIVES: 1) How to get ready: Read Chapters 25 and 26, McKinley et al., Human Anatomy, 4e. All text references are for this textbook. 2) Identify structures
More informationBone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint
Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): Flow Cytometry (L34513) Document Information
Local Coverage Determination (LCD): Flow Cytometry (L34513) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor Name Contract
More informationCrosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15
1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1
More informationSHN-1 Human Digestive Panel Test results
SHN-1 Human Digestive Panel Test results HN-30 tongue HN-24 salivary gland HN-12 larynx HN-28 esophagus HN-29 stomach HN-20 pancreas HN-13 liver HN-14 gall bladder HN-27-1 duodenum HN-27-2 ileum HN-27-3
More informationGeneral Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p.
General Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p. 10 Principal Joints (Immovable) p. 12 Synovial Joints
More informationCODING PRIMARY SITE. Nadya Dimitrova
CODING PRIMARY SITE Nadya Dimitrova OUTLINE What is coding and why do we need it? ICD-10 and ICD-O ICD-O-3 Topography coding rules ICD-O-3 online WHAT IS CODING AND WHY DO WE NEED IT? Coding: to assign
More informationLinks in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website.
Local Coverage Determination (LCD): Flow Cytometry (L34215) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor Name Contract
More informationRESPIRATORY SYSTEM. described: pp. 744,746 fig. 25.1, described: p. 746 fig described: p. 776 fig. 26.3
ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS OBJECTIVES: 1) How to get ready: Read Chapters 25 and 26, McKinley et al., Human Anatomy, 5e. All text references are for this textbook. 2) Identify structures
More informationList of Codes Used to Identify Measures Reported in the Dialysis Facility Report for FY 2019
List of Codes Used to Identify Measures Reported in the Dialysis Facility Report for FY 2019 Table of Contents Table 4: Hospitalization Summary for Medicare Dialysis Patients... 4 SEPTICEMIA 4 MYOCARDIAL
More informationThis lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors
1 This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors 2 A. Digestive System Overview To Start: Go to the Views menu and scroll down to the
More information2012 Cancer Report 2011 Registry Data
2012 Cancer Report 2011 Registry Data Contents Goals and Objectives 1 2012 Cancer Committee Members 2 Total Cancer Cases 1981-2011 3 Cancer Registry Frequency Report 1981-2011 4-5 Cancer Registry Frequency
More informationGlobally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute
Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Paul R. Yarnold, Ph.D. and Robert C. Soltysik, M.S. Optimal Data Analysis, LLC Imagine a random sample
More informationDescriptive Histology
Atlas of Descriptive Histology Michael H. Ross University of Florida College of Medicine Gainesville, Florida Wojciech Pawlina Mayo Medical School College of Medicine, Mayo Clinic Rochester, Minnesota
More information2016 Cancer Registry Annual Report
2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,
More informationReviewing the ICD-10 classification of haematological neoplasms on its way to ICD-11
WHO-FIC NETWORK MEETING Tokyo, Japan haematological neoplasms on its way to ICD-11 Ulrich Vogel, Robert Jakob, Michael Schopen, Harald Stein, Stefan Krause Abstract: haematological neoplasms on its way
More informationRAMATHIBODI CANCER REPORT
RAMATHIBODI CANCER REPORT 2016 Ramathibodi Cancer Registry : A subsidiary of Ramathibodi Comprehensive Cancer Center Faculty of Medicine, Ramathibodi Hospital Mahidol University Table of content INTRODUCTION...III
More informationOVARIES URETER FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS
URETER OVARIES FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS REPRODUCTIVE PRODUCE FEMALE HORMONES EXCRETORY FROM KIDNEY TO BLADDER EXCRETORY STORES URINE REPRODUCTIVE TRANSPORTS
More informationLungs a. d. b. c. e.
Lungs d. e. Lungs Right superior lobe Right middle lobe Right inferior lobe d. Left superior lobe e. Left inferior lobe Sinuses d. Nasal Cavity & Sinuses g. g. i. Nasal Cavity & Sinuses g. h. d. f. e.
More information*
Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.138.MH Oral Maxillofacial Prosthesis This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP MedStar CareFirst
More informationContractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC A. LCD ID Number: L35032 Status: A-Approved
LCD for Flow Cytometry (L35032) Contractor Name: Novitas Solutions, Inc. Contractor Number: 12501 Contractor Type: MAC A LCD ID Number: L35032 Status: A-Approved Contractor Information LCD Information
More informationHuman Anatomy & Physiology. Introduction (Ch. 1)
Human Anatomy & Physiology Introduction (Ch. 1) Overview of Anatomy and Physiology Anatomy the study of the structure of body parts and their relationships to one another Gross or macroscopic Microscopic
More informationLab 5 Digestion and Hormones of Digestion. 7/16/2015 MDufilho 1
Lab 5 Digestion and Hormones of Digestion 1 Figure 23.1 Alimentary canal and related accessory digestive organs. Mouth (oral cavity) Tongue* Parotid gland Sublingual gland Submandibular gland Salivary
More informationAMBULATORY SURGERY CENTER CODING AND PAYMENT GUIDE
Targeted Drug Delivery AMBULATORY SURGERY CENTER CODING AND PAYMENT GUIDE 2018 Flowonix Medical has compiled this coding information for your convenience. This information is gathered from third party
More informationTable S1. International classification of disease (ICD)-9 codes and descriptions of malignancy. types. Additional file 1
Additional file 1 Table S1. International classification of disease (ICD)-9 codes and descriptions of malignancy types. Malignancy Type ICD-9 Description Bone & Soft-tissue 170.0-170.9 Malignant neoplasm
More informationJhia Anjela D. Rivera 1 1. BS Biology, Department of Biology, College of Science, Polytechnic University of the Philippines
DIGESTIVE SYSTEM Jhia Anjela D. Rivera 1 1 BS Biology, Department of Biology, College of Science, Polytechnic University of the Philippines DIGESTIVE SYSTEM Consists of the digestive tract (gastrointestinal
More informationCancer survival in Shanghai, China,
Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely
More informationHOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind
More informationChapter II: Overview
: Overview Chapter II: Overview This chapter provides an overview of the status of cancer in Minnesota, using cases reported to the Minnesota Cancer Surveillance System (MCSS) and deaths reported to the
More informationNational Cancer Patient Experience Survey 2016 Technical Documentation July 2017
National Cancer Patient Experience Survey 2016 Technical Documentation July 2017 1 Contents 1. Introduction 2. Scoring 3. Significance Tests (for national data) 4. Case-mix Adjustment (for local data)
More informationAmerican Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,
More informationVeins of the Face and the Neck
Veins of the Face and the Neck Facial Vein The facial vein is formed at the medial angle of the eye by the union of the supraorbital and supratrochlear veins. connected through the ophthalmic veins with
More informationAll Discovered Death Outcome Detail (Form 124/120)
This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877
More informationAnatomy: Know Your Abdomen
Anatomy: Know Your Abdomen Glossary Abdomen - part of the body below the thorax (chest cavity); separated by the diaphragm. Anterior - towards the front of the body. For example, the umbilicus is anterior
More informationLumbar MRI. Noridian Healthcare Solutions, LLC
Lumbar MRI Noridian Healthcare Solutions, LLC Please Note: This is a Proposed LCD. Proposed LCDs are works in progress and not necessarily a reflection of the current policies or practices. Proposed LCDs
More informationFig. A.1. Frontal. plane. Transverse. plane. Sagittal plane. Copyright McGraw-Hill Education. Permission required for reproduction or display.
Fig. A.1 Frontal plane Transverse plane Sagittal plane McGraw-Hill Education/Joe DeGrandis Fig. A.2 (a) Sagittal section (b) Frontal section (c) Transverse section Table A.1 Fig. A.3 Cephalic r. (head)
More informationLinks in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website.
PROPOSED/DRAFT Local Coverage Determination (LCD): CT of the Head (DL34417) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Please note: This is a Proposed/Draft
More information